Pfizer Could Year-End Target Hit on 2-to-1 Trial Payoff
Pfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
Knowing what to include helps you prepare quickly. This intro highlights essential categories and a simple framework for an effective emergency budget.
15,316 articlesPfizer stock climbs as analysts weigh a pivotal prostate cancer trial. A Guggenheim bull case sees a $36 target by ye...
A recently launched XRP-focused ETF aims to deliver 3% monthly income by selling XRP call options, blending crypto ex...
Oil’s surge fuels a wave of gains in key energy ETFs, led by XLE, OIH, and PBT, as supply, demand, and drilling budge...
Investors are weighing a shift from high-growth tech to more income-driven energy plays as AI-era capex creates uncer...